Identifying Genetic Causes of IC/BPS
Launched by BOSTON CHILDREN'S HOSPITAL · Oct 17, 2006
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the genetic causes of interstitial cystitis (IC), bladder pain syndrome (BPS), and chronic pelvic pain syndrome (CPPS). These conditions can cause ongoing pelvic pain and frequent urination, yet the exact reasons for them remain unclear. Researchers believe that genetics may play a role, as studies with twins and families suggest these conditions could be inherited. By collecting genetic samples and medical information from individuals and their families in North America, the trial aims to identify any genetic factors that might be linked to these painful conditions.
If you or a family member has been diagnosed with IC, BPS, or CPPS, you may be eligible to participate in this study. The trial is open to people of all ages, starting from 7 years old, and welcomes both males and females. To join, participants should have symptoms like frequent urination (more than once an hour), pelvic pain lasting three months or longer, or discomfort when urinating. Participants will provide genetic samples and medical history, and they may also include family members who do or do not have symptoms. This study is currently recruiting, and your involvement could help uncover important insights into these conditions, possibly leading to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of IC/BPS
- • Males and females of any age
- • Urinary frequency - more than 1X/hour, and/or
- • Dysuria, and/or
- • Pelvic, suprapubic, or abdominal pain - for 3 months or longer
- • Nocturia
- • Normal urinary stream (by history)
- • No evidence of active bacterial UTI (no pyuria \& negative urinary culture for last 3 months)
- • First degree relative of someone with above symptoms
- Exclusion Criteria:
- • Major structural/anatomical urinary tract abnormalities by ultrasound
- • Underlying inborn conditions affecting the urinary tract
- • Surgery/chemotherapy affected pelvic area
- • GI or GU cancers
- • Severe Constipation in children only
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Catherine Brownstein, Ph.D.
Principal Investigator
Boston Children's Hosptial
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials